Angiotensin II Receptor Type 1—A Novel Target for Preventing Neonatal Meningitis in Mice by Escherichia coli K1
Open Access
- 16 September 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 209 (3) , 409-419
Abstract
The increasing incidence of Escherichia coli K1 meningitis due to escalating antibiotic resistance warrants alternate treatment options to prevent this deadly disease. We screened a library of small molecules from the National Institutes of Health clinical collection and identified telmisartan, an angiotensin II receptor type 1 (AT1R) blocker, as a potent inhibitor of E. coli invasion into human brain microvascular endothelial cells (HBMECs). Immunoprecipitation studies revealed that AT1R associates with endothelial cell gp96, the receptor in HBMECs for E. coli outer membrane protein A. HBMECs pretreated with telmisartan or transfected with AT1R small interfering RNA were resistant to E. coli invasion because of downregulation of protein kinase C-α phosphorylation. Administration of a soluble derivative of telmisartan to newborn mice before infection with E. coli prevented the onset of meningitis and suppressed neutrophil infiltration and glial cell migration in the brain. Therefore, telmisartan has potential as an alternate treatment option for preventing E. coli meningitis.Keywords
This publication has 25 references indexed in Scilit:
- Attenuation of Biopterin Synthesis Prevents Escherichia coli K1 Invasion of Brain Endothelial Cells and the Development of Meningitis in Newborn MiceThe Journal of Infectious Diseases, 2012
- Meningococcus Hijacks a β2-Adrenoceptor/β-Arrestin Pathway to Cross Brain Microvasculature EndotheliumCell, 2010
- Chaperones contribute to G protein coupled receptor oligomerization, but do not participate in assembly of the G protein with the receptor signaling complexJournal of Molecular Signaling, 2010
- IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitisJournal of Experimental Medicine, 2010
- Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III SecretionAntimicrobial Agents and Chemotherapy, 2010
- Inhibition of Inducible Nitric Oxide Controls Pathogen Load and Brain Damage by Enhancing Phagocytosis of Escherichia coli K1 in Neonatal MeningitisThe American Journal of Pathology, 2010
- CTX-M β-Lactamase Production and Virulence ofEscherichia coliK1Emerging Infectious Diseases, 2009
- Novel Model To Study Virulence Determinants of Escherichia coli K1Infection and Immunity, 2007
- Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1receptorBritish Journal of Pharmacology, 2007
- Neuroprotective Effects of Angiotensin II Type 1 Receptor (AT1R) Blocker, Telmisartan, via Modulating AT1R and AT2R Signaling in Retinal InflammationInvestigative Ophthalmology & Visual Science, 2006